{"id":"https://openalex.org/W2559520077","doi":"https://doi.org/10.1182/blood.v108.11.5209.5209","title":"Stimulation of Anti-Tumor Immunity Using Dendritic Cells Transduced with Fowl Pox Vector Expressing MUC-1 and Costimulatory Molecules (PANVAC-F).","display_name":"Stimulation of Anti-Tumor Immunity Using Dendritic Cells Transduced with Fowl Pox Vector Expressing MUC-1 and Costimulatory Molecules (PANVAC-F).","publication_year":2006,"publication_date":"2006-11-16","ids":{"openalex":"https://openalex.org/W2559520077","doi":"https://doi.org/10.1182/blood.v108.11.5209.5209","mag":"2559520077"},"language":"en","primary_location":{"id":"doi:10.1182/blood.v108.11.5209.5209","doi":"https://doi.org/10.1182/blood.v108.11.5209.5209","is_oa":false,"landing_page_url":"https://doi.org/10.1182/blood.v108.11.5209.5209","pdf_url":null,"source":{"id":"https://openalex.org/S200071133","display_name":"Blood","issn_l":"0006-4971","issn":["0006-4971","1528-0020"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Blood","raw_type":"journal-article"},"volume":null,"type":"article","indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5072612101","display_name":"Baldev Vasir","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210117453","display_name":"Dana-Farber Cancer Institute","ror":"https://ror.org/02jzgtq86","country_code":"US","type":"facility","lineage":["https://openalex.org/I4210117453"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"Baldev Vasir","raw_affiliation_strings":["Adult Oncology, Dana Farber Cancer Institute, Boston, MA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Adult Oncology, Dana Farber Cancer Institute, Boston, MA, USA","institution_ids":["https://openalex.org/I4210117453"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5110451587","display_name":"Corrine Lenahan","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1316535847","display_name":"Beth Israel Deaconess Medical Center","ror":"https://ror.org/04drvxt59","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1316535847"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"Corrine Lenahan","raw_affiliation_strings":["Medicine-Hematology/Oncology, Beth Israel Deaconess Medical Center, Boston, MA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Medicine-Hematology/Oncology, Beth Israel Deaconess Medical Center, Boston, MA, USA","institution_ids":["https://openalex.org/I1316535847"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5054346063","display_name":"Jacalyn M. Rosenblatt","orcid":"https://orcid.org/0000-0001-5582-8161","observed_orcids":["https://orcid.org/0000-0001-5582-8161"]},"institutions":[{"id":"https://openalex.org/I1316535847","display_name":"Beth Israel Deaconess Medical Center","ror":"https://ror.org/04drvxt59","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1316535847"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Jacalyn Rosenblatt","raw_affiliation_strings":["Medicine-Hematology/Oncology, Beth Israel Deaconess Medical Center, Boston, MA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Medicine-Hematology/Oncology, Beth Israel Deaconess Medical Center, Boston, MA, USA","institution_ids":["https://openalex.org/I1316535847"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5022280493","display_name":"Adam M. Bissonnette","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210117453","display_name":"Dana-Farber Cancer Institute","ror":"https://ror.org/02jzgtq86","country_code":"US","type":"facility","lineage":["https://openalex.org/I4210117453"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"Adam Bissonnette","raw_affiliation_strings":["Adult Oncology, Dana Farber Cancer Institute, Boston, MA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Adult Oncology, Dana Farber Cancer Institute, Boston, MA, USA","institution_ids":["https://openalex.org/I4210117453"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5100986988","display_name":"Zekui Wu","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210117453","display_name":"Dana-Farber Cancer Institute","ror":"https://ror.org/02jzgtq86","country_code":"US","type":"facility","lineage":["https://openalex.org/I4210117453"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"Zekui Wu","raw_affiliation_strings":["Adult Oncology, Dana Farber Cancer Institute, Boston, MA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Adult Oncology, Dana Farber Cancer Institute, Boston, MA, USA","institution_ids":["https://openalex.org/I4210117453"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5067054634","display_name":"Donald W. Kufe","orcid":"https://orcid.org/0000-0001-5743-8888","observed_orcids":["https://orcid.org/0000-0001-5743-8888"]},"institutions":[{"id":"https://openalex.org/I4210117453","display_name":"Dana-Farber Cancer Institute","ror":"https://ror.org/02jzgtq86","country_code":"US","type":"facility","lineage":["https://openalex.org/I4210117453"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"Donald Kufe","raw_affiliation_strings":["Adult Oncology, Dana Farber Cancer Institute, Boston, MA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Adult Oncology, Dana Farber Cancer Institute, Boston, MA, USA","institution_ids":["https://openalex.org/I4210117453"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5052641327","display_name":"David Avigan","orcid":"https://orcid.org/0000-0003-4624-6017","observed_orcids":["https://orcid.org/0000-0003-4624-6017"]},"institutions":[{"id":"https://openalex.org/I1316535847","display_name":"Beth Israel Deaconess Medical Center","ror":"https://ror.org/04drvxt59","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1316535847"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"David Avigan","raw_affiliation_strings":["Medicine-Hematology/Oncology, Beth Israel Deaconess Medical Center, Boston, MA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Medicine-Hematology/Oncology, Beth Israel Deaconess Medical Center, Boston, MA, USA","institution_ids":["https://openalex.org/I1316535847"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":2,"corresponding_author_ids":["https://openalex.org/A5022280493","https://openalex.org/A5067054634","https://openalex.org/A5072612101","https://openalex.org/A5100986988","https://openalex.org/A5110451587"],"corresponding_institution_ids":["https://openalex.org/I1316535847","https://openalex.org/I4210117453"],"apc_list":{"value":5500,"currency":"USD","value_usd":5500},"apc_paid":null,"fwci":0.0,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":{"value":0.30847106,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":null,"biblio":{"volume":"108","issue":"11","first_page":"5209","last_page":"5209"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10580","display_name":"Immunotherapy and Immune Responses","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T10580","display_name":"Immunotherapy and Immune Responses","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10031","display_name":"T-cell and B-cell Immunology","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T12996","display_name":"Cancer Research and Treatments","score":0.0,"subfield":{"id":"https://openalex.org/subfields/1305","display_name":"Biotechnology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/dendritic-cell-transduction","display_name":"dendritic cell transduction","score":0.746999979019165},{"id":"https://openalex.org/keywords/muc1","display_name":"MUC1","score":0.9810000061988831},{"id":"https://openalex.org/keywords/carcinoembryonic-antigen","display_name":"carcinoembryonic antigen","score":0.890999972820282},{"id":"https://openalex.org/keywords/costimulatory-molecules","display_name":"costimulatory molecules","score":0.9419999718666077},{"id":"https://openalex.org/keywords/antitumor-immunity","display_name":"antitumor immunity","score":0.7820000052452087},{"id":"https://openalex.org/keywords/dendritic-cell-maturation","display_name":"dendritic cell maturation","score":0.8190000057220459},{"id":"https://openalex.org/keywords/regulatory-t-cells","display_name":"regulatory T cells","score":0.7260000109672546},{"id":"https://openalex.org/keywords/cancer-vaccines","display_name":"cancer vaccines","score":0.34700000286102295},{"id":"https://openalex.org/keywords/cd83","display_name":"CD83","score":0.5170000195503235},{"id":"https://openalex.org/keywords/ccr7","display_name":"CCR7","score":0.7889999747276306},{"id":"https://openalex.org/keywords/tumor-antigens","display_name":"tumor antigens","score":0.40400001406669617},{"id":"https://openalex.org/keywords/vaccine-safety-and-tolerability","display_name":"vaccine safety and tolerability","score":0.3310000002384186}],"concepts":[{"id":"https://openalex.org/C2778297628","wikidata":"https://www.wikidata.org/wiki/Q5009843","display_name":"CD80","level":5,"score":0.694995105266571},{"id":"https://openalex.org/C2778170410","wikidata":"https://www.wikidata.org/wiki/Q506253","display_name":"Dendritic cell","level":3,"score":0.6241852045059204},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.6136897206306458},{"id":"https://openalex.org/C8891405","wikidata":"https://www.wikidata.org/wiki/Q1059","display_name":"Immune system","level":2,"score":0.5821296572685242},{"id":"https://openalex.org/C147483822","wikidata":"https://www.wikidata.org/wiki/Q103537","display_name":"Antigen","level":2,"score":0.5416754484176636},{"id":"https://openalex.org/C2781101188","wikidata":"https://www.wikidata.org/wiki/Q5009846","display_name":"CD86","level":4,"score":0.5416747331619263},{"id":"https://openalex.org/C32470452","wikidata":"https://www.wikidata.org/wiki/Q2298489","display_name":"Viral vector","level":4,"score":0.5200393199920654},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.45769673585891724},{"id":"https://openalex.org/C159047783","wikidata":"https://www.wikidata.org/wiki/Q7215","display_name":"Virology","level":1,"score":0.3420772850513458},{"id":"https://openalex.org/C2776090121","wikidata":"https://www.wikidata.org/wiki/Q193529","display_name":"T cell","level":3,"score":0.31080901622772217},{"id":"https://openalex.org/C39347974","wikidata":"https://www.wikidata.org/wiki/Q21135811","display_name":"CD40","level":4,"score":0.2691032886505127},{"id":"https://openalex.org/C154317977","wikidata":"https://www.wikidata.org/wiki/Q376266","display_name":"Cytotoxic T cell","level":3,"score":0.16364765167236328},{"id":"https://openalex.org/C202751555","wikidata":"https://www.wikidata.org/wiki/Q221681","display_name":"In vitro","level":2,"score":0.14765679836273193},{"id":"https://openalex.org/C40767141","wikidata":"https://www.wikidata.org/wiki/Q285697","display_name":"Recombinant DNA","level":3,"score":0.08221074938774109},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.0},{"id":"https://openalex.org/C104317684","wikidata":"https://www.wikidata.org/wiki/Q7187","display_name":"Gene","level":2,"score":0.0}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1182/blood.v108.11.5209.5209","doi":"https://doi.org/10.1182/blood.v108.11.5209.5209","is_oa":false,"landing_page_url":"https://doi.org/10.1182/blood.v108.11.5209.5209","pdf_url":null,"source":{"id":"https://openalex.org/S200071133","display_name":"Blood","issn_l":"0006-4971","issn":["0006-4971","1528-0020"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Blood","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":1.0}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2064709715","https://openalex.org/W2050653614","https://openalex.org/W2166026289","https://openalex.org/W2547399801","https://openalex.org/W2326782958","https://openalex.org/W2272739834","https://openalex.org/W2034494579","https://openalex.org/W2125886382","https://openalex.org/W7097603530","https://openalex.org/W1552063778"],"abstract_inverted_index":{"Abstract":[0],"In":[1,149,177,347],"pre-clinical":[2],"models,":[3],"vaccination":[4,395],"with":[5,44,77,125,132,137,154,167,236,309,311,326,378,396,401],"attenuated":[6],"vaccinia":[7],"and":[8,15,20,51,85,93,127,135,147,196,231,240,252,254,303],"fowl":[9,79],"pox":[10,80],"virus":[11],"expressing":[12,82,369],"tumor":[13,272,365],"antigens":[14],"costimulatory":[16],"molecules":[17],"(CD54/ICAM-1;":[18],"CD58/LFA-1":[19],"CD80/B7.1-TRICOM)":[21],"potently":[22],"stimulates":[23],"anti-tumor":[24,407],"immune":[25],"responses.":[26],"However,":[27],"vaccine":[28],"efficacy":[29],"may":[30],"be":[31,390,412],"limited":[32],"by":[33,115],"intrinsic":[34],"deficiencies":[35],"of":[36,63,74,143,165,173,185,187,207,250,261,268,278,290,323,354],"native":[37],"dendritic":[38],"cells":[39,121,166,280,293,305],"(DC)":[40],"populations":[41,343,359],"in":[42,157,161,301,381,386,409],"patients":[43,377,388],"malignancy":[45],"that":[46,226],"are":[47,372],"required":[48],"to":[49,88,98,218,244,270,317,328,338,392,405],"process":[50],"present":[52],"the":[53,61,72,141,208,266,276,282],"virally":[54],"introduced":[55],"antigens.":[56],"An":[57,299],"alternative":[58],"strategy":[59],"involves":[60],"transduction":[62,153,227],"ex":[64],"vivo":[65,410],"generated":[66,107],"activated":[67,95,333],"DCs.":[68],"We":[69,371],"have":[70],"examined":[71],"capacity":[73,322,404],"DCs":[75,105,129,180,203,220,234,314,319,324,351,399],"transduced":[76,131,179,202,313,325,350,400],"a":[78,168,255,374,415],"vector":[81,134],"MUC-1,":[83],"CEA,":[84],"TriCOM":[86],"(PANVAC-F)":[87],"elicit":[89],"antigen":[90,273,355],"specific":[91,274,284,356],"responses":[92],"expand":[94],"as":[96,216,242,315,336,364,414],"compared":[97,217,243,316,337],"regulatory":[99,340],"T":[100,279,292,334,341,357],"cell":[101,342,358],"populations.":[102],"Partially":[103],"mature":[104],"were":[106,130,306],"from":[108,112,295],"leukopak":[109],"preparations":[110],"obtained":[111],"normal":[113],"volunteers":[114],"culturing":[116],"adherent":[117],"peripheral":[118],"blood":[119],"mononuclear":[120],"for":[122,367,376],"5":[123,150],"days":[124],"GM-CSF":[126],"IL-4.":[128],"PANVAC-F":[133,155,269,312,327,349],"matured":[136,235],"either":[138],"TNFa":[139,245],"or":[140,398],"combination":[142],"PG-E2,":[144],"TNFa,":[145,238],"IL-6":[146,239],"IL-1b.":[148],"serial":[151,394],"studies,":[152],"resulted":[156],"mean":[158,169],"MUC1":[159],"expression":[160,186],"64.6%":[162],"(SEM:":[163,175,222],"\u00b11.6)":[164],"fluorescent":[170],"intensity":[171],"(MFI)":[172],"249.8":[174],"\u00b145.7).":[176],"addition,":[178],"also":[181],"demonstrated":[182,204,247],"high":[183],"levels":[184,206,249],"class":[188],"II":[189],"(99%;":[190],"MFI:250),":[191],"CD54":[192],"(98.4%;MFI:516),":[193],"CD58":[194],"(98.8%;MFI:155)":[195],"CD80":[197],"(78.2%;":[198],"MFI:115).":[199],"Of":[200],"note,":[201],"higher":[205,248],"maturation":[209,230],"marker":[210],"CD83":[211,251],"(40.3%;":[212],"SEM:":[213],"\u00b11.6,":[214],"n=3)":[215],"untransduced":[219,318],"19.7%":[221],"\u00b12.9)":[223],"(p=0.02)":[224],"suggesting":[225,360],"enhanced":[228],"DC":[229],"activation.":[232],"Transduced":[233],"PGE2,":[237],"IL-1b":[241],"alone":[246],"CCR7":[253],"more":[256],"stable":[257],"phenotype":[258],"following":[259,288],"withdrawal":[260],"cytokine":[262],"support.":[263],"To":[264],"assess":[265],"ability":[267],"stimulate":[271,329,352],"responses,":[275],"presence":[277],"binding":[281],"MUC-1":[283],"tetramer":[285],"was":[286],"quantified":[287],"stimulation":[289,310],"autologous":[291],"derived":[294],"HLA*0201":[296],"healthy":[297],"donors.":[298],"increase":[300],"CD8+":[302],"MUC1+":[304],"observed":[307],"(8.3%)":[308],"(2.5%).":[320],"The":[321,403],"interferon":[330],"gamma":[331],"producing":[332],"cells,":[335],"CD4+/CD25+/Foxp3+":[339],"is":[344],"being":[345],"assessed.":[346],"summary,":[348],"expansion":[353],"their":[361],"potential":[362],"role":[363],"vaccines":[366],"MUC-1/CEA":[368],"tumors.":[370],"initiating":[373],"trial":[375],"ovarian":[379],"carcinoma":[380],"early":[382],"(marker":[383],"only)":[384],"relapse":[385],"which":[387],"will":[389,411],"randomized":[391],"undergo":[393],"PANVAC-V/PANVAC-F":[397],"PANVAC-F.":[402],"generate":[406],"immunity":[408],"assessed":[413],"primary":[416],"endpoint.":[417]},"counts_by_year":[],"updated_date":"2026-09-22T06:50:58.402377","created_date":"2016-12-08T00:00:00"}